Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Immunotherapy in Pollen Allergic Asthma
NCT03394508Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of birch allergen extract + grass allergen extract in allergic rhinitis (AR), asthma, sponsored by Karolinska Institutet. Started Jan 2013; status: completed.
02
Drugs
birch allergen extract + grass allergen extract
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on NCT03394508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394508.